Suven Life Sciences Limited
Suven Life Sciences Limited, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in drug discovery and development, focusing on central nervous system disorders and other therapeutic areas. With a robust portfolio of innovative products and services, Suven Life Sciences is renowned for its unique approach to developing novel compounds that address unmet medical needs. The company has achieved significant milestones, including successful collaborations and partnerships that enhance its market position. Operating primarily in India and expanding its reach globally, Suven Life Sciences continues to make strides in the industry, driven by a commitment to research excellence and patient-centric solutions.
DitchCarbon Score
How does Suven Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suven Life Sciences Limited's score of 26 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Suven Life Sciences Limited's reported carbon emissions
In 2023, Suven Life Sciences Limited reported total carbon emissions of approximately 864,567 kg CO2e, comprising 31,483 kg CO2e from Scope 1 and 833,084 kg CO2e from Scope 2. This represents a slight decrease in emissions compared to 2022, where total emissions were about 890,219 kg CO2e, with Scope 1 emissions at 31,101 kg CO2e and Scope 2 emissions at 859,118 kg CO2e. For 2024, the company anticipates further reductions, with projected emissions of approximately 888,615 kg CO2e, including 30,539 kg CO2e from Scope 1 and 858,076 kg CO2e from Scope 2. Despite these reductions, Suven Life Sciences has not set specific reduction targets or climate pledges, indicating a potential area for future commitment. The company continues to monitor its emissions and aims to improve its carbon footprint in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 31,101 | 00,000 | 00,000 |
| Scope 2 | 859,118 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Suven Life Sciences Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
